Inpatient and Outpatient Orderable

Cholinesterase, Serum, with Dibucaine Inhibition

Synonyms

  • DIBUCAIN INHIBITOR TEST
  • LAB11614
  • PCHODEB
  • PSUEDOCHOLINESTERASE DIBUCAINE NUMBER

Cerner Name

Pseudocholinesterase Dibucain

Clinical Info

The Pseudocholinesterase phenotype can be determined by analysis of Pseudocholinesterase and the percent inhibition by Dibucaine.
 

Specimen Sources

Blood, Arterial Blood, Capillary Blood, Central Line Blood, Venous

Specimen Types

Blood

Container

Red Top Tube

Collection Instructions

Container/Tube: Red Top tube or Gold Top Tube
Specimen: 1 mL serum ( 0.5 mL min)
Transport Temperature: Refrigerate

Specimen Volume

1 mL serum ( 0.5 mL min)

Transport Instructions

Refrigerate

Specimen Stability

21 Days Room Temperature
21 Days Refrigerated
30 Days Frozen

Methodology

Kinetic Spectrophotometric (KS)

Days Performed

TAT: 2-3 Days

Performing Laboratory

Quest Diagnostics' Nichols Institute, Inc. - Chantilly

CPT

82638

PDM

5901132

Only Orderable at Locations:

Orderable Everywhere

Results
Component Name Base Name Common Name External Name
CHOLINESTERASE, RBC CHOLINESTER CHOLINESTERASE, RBC Cholinesterase
DIBUCAINE NUMBER LABDIBU DIBUCAINE NUMBER Dibucaine Number

Result Interpretation

Colinesterase, Serum
  Male: 3342-7586 IU/L
  Female: 2673-6592  IU/L
Dibucaine Number  81.6 - 88.3 % Inhibition

Cholinesterase with Dibucaine Inhibition

Phenotype % Inhibition

U

 83.6
A* 19.9
AS* 20.7
S1* 5.3
S2* 67.6
F* 71.8
AF* 60.2
FS* 76.7
UA 72.7
UF 79.8
US 84.4

* Phenotype reportedly associated with prolonged apnea.

Forms
LAB11614 build edit